Skip to Main Content

Author Details

Jared J Gartner
Center for Cancer Research, National Cancer Institute, National Institutes of Health
2006
61
34
PMIDPaper TitleJournal TitlePublished Year
37368077Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens.Cancer Immunol Immunother2023
38039963Phenotypic signatures of circulating neoantigen-reactive CD8<sup>+</sup> T cells in patients with metastatic cancers.Cancer Cell2023
37258038Cell surface marker-based capture of neoantigen-reactive CD8<sup>+</sup> T-cell receptors from metastatic tumor digests.J Immunother Cancer2023
37368077Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens.Cancer Immunol Immunother2023
37045473Specific recognition of an <i>FGFR2</i> fusion by tumor infiltrating lymphocytes from a patient with metastatic cholangiocarcinoma.J Immunother Cancer2023
38039963Phenotypic signatures of circulating neoantigen-reactive CD8<sup>+</sup> T cells in patients with metastatic cancers.Cancer Cell2023
37258038Cell surface marker-based capture of neoantigen-reactive CD8<sup>+</sup> T-cell receptors from metastatic tumor digests.J Immunother Cancer2023
37045473Specific recognition of an <i>FGFR2</i> fusion by tumor infiltrating lymphocytes from a patient with metastatic cholangiocarcinoma.J Immunother Cancer2023
35104158Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes.J Clin Oncol2022
35452604A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers.Cancer Cell2022
36007524Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade.Med2022
35749374Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors.Cancer Immunol Res2022
35247926Neoantigen Identification and Response to Adoptive Cell Transfer in Anti-PD-1 Naïve and Experienced Patients with Metastatic Melanoma.Clin Cancer Res2022
35113651Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers.Science2022
35104158Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes.J Clin Oncol2022
35452604A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers.Cancer Cell2022
35749374Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors.Cancer Immunol Res2022
36007524Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade.Med2022
35247926Neoantigen Identification and Response to Adoptive Cell Transfer in Anti-PD-1 Naïve and Experienced Patients with Metastatic Melanoma.Clin Cancer Res2022
35113651Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers.Science2022
34168045Identification and Validation of T-cell Receptors Targeting <i>RAS</i> Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy.Clin Cancer Res2021
34168045Identification and Validation of T-cell Receptors Targeting <i>RAS</i> Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy.Clin Cancer Res2021
34266885Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma.J Immunother Cancer2021
34321276Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing.J Immunother Cancer2021
34927080A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor types.Nat Cancer2021
34927080A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor types.Nat Cancer2021
34321276Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing.J Immunother Cancer2021
34266885Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma.J Immunother Cancer2021
33016924mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer.J Clin Invest2020
33303615Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer.Science2020
33016924mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer.J Clin Invest2020
33303615Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer.Science2020
30683863Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients.Nat Commun2019
31609250Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes.J Clin Invest2019
31036766Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer.J Immunol2019
30905807Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities.J Invest Dermatol2019
30683863Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients.Nat Commun2019
31164343Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers.Cancer Discov2019
30850615Author Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells.Sci Rep2019
30714987Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers.J Clin Invest2019
31408414T-Cell Receptor Gene Therapy for Human Papillomavirus-Associated Epithelial Cancers: A First-in-Human, Phase I/II Study.J Clin Oncol2019
30709841Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer.Cancer Immunol Res2019
31609250Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes.J Clin Invest2019
31408414T-Cell Receptor Gene Therapy for Human Papillomavirus-Associated Epithelial Cancers: A First-in-Human, Phase I/II Study.J Clin Oncol2019
30714987Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers.J Clin Invest2019
30709841Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer.Cancer Immunol Res2019
31036766Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer.J Immunol2019
31164343Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers.Cancer Discov2019
30850615Author Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells.Sci Rep2019
30905807Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities.J Invest Dermatol2019
  • 1 - 50 of 122

Recommended Authors

Mary A Wood
Phase Genomics Inc.
Career Start Year 2018
Number of shared co-authors 0
Megan M Richters
Washington University School of Medicine
Career Start Year 2016
Number of shared co-authors 0
Scott D Brown
BC Cancer Research Institute
Career Start Year 2014
Number of shared co-authors 1
Katie M Campbell
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2014
Number of shared co-authors 0
Jasreet Hundal
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 4
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 2
Mitchell P Levesque
University Hospital Zurich
Career Start Year 2009
Number of shared co-authors 9
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 2
Benjamin G Vincent
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 2008
Number of shared co-authors 2
Phil F Cheng
University Hospital of Zurich
Career Start Year 2007
Number of shared co-authors 8
Jesse M Zaretsky
University of California los angeles
Career Start Year 2007
Number of shared co-authors 0
Lawrence N Kwong
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 3
Samuel S Freeman
St Vincent's Hospital Melbourne
Career Start Year 2006
Number of shared co-authors 0
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 6
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 2
Malachi Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 4
Fengshen Kuo
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Harriet M Kluger
Yale School of Medicine
Career Start Year 2003
Number of shared co-authors 7
Suchit Jhunjhunwala
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 0
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 4
Ludmila Danilova
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year 2001
Number of shared co-authors 3
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 6
Cindy Sander
UPMC Hillman Cancer Center
Career Start Year 1997
Number of shared co-authors 2
Timothy A Chan
Cleveland Clinic.
Career Start Year 1994
Number of shared co-authors 3
Marcus Bosenberg
Yale School of Medicine
Career Start Year 1992
Number of shared co-authors 14
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 9
Levi A Garraway
Broad Institute of Harvard and MIT
Career Start Year 1991
Number of shared co-authors 5
Grant A McArthur
University of Melbourne
Career Start Year 1986
Number of shared co-authors 6
Dave S B Hoon
Saint John's Cancer Institute at Saint John's Health Center
Career Start Year 1982
Number of shared co-authors 6

Collaborators

Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 50
Todd D Prickett
National Cancer Institute
Co-authored papers 35
Yardena Samuels
Weizmann Institute of Science
Co-authored papers 20
Satyajit Ray
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 12
Jimmy C Lin
National Human Genome Research Institute, US National Institutes of Health
Co-authored papers 12
Xiaomu Wei
Cornell University
Co-authored papers 7
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 6
Nicholas K Hayward
QIMR Berghofer Medical Research Institute
Co-authored papers 6
John R Wunderlich
National Cancer Institute
Co-authored papers 6
Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
Jeffrey E Gershenwald
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Michael A Davies
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Richard A Scolyer
Co-authored papers 4
Ken Dutton-Regester
QIMR Berghofer Medical Research Institute
Co-authored papers 4
Elliott H Margulies
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 4
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers 4
Steven E Robinson
University of Colorado Anschutz Medical Campus
Co-authored papers 4
Nicholas P Restifo
National Cancer Institute, National Institutes of Health (NIH)
Co-authored papers 3
Susan R Davis
Co-authored papers 3
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 3
Vijay Walia
National Center for Toxicological Research
Co-authored papers 3
Abdel G Elkahloun
National Human Genome Research Institute
Co-authored papers 3
Stephen C J Parker
University of Michigan ann arbor
Co-authored papers 3
Nancy F Hansen
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 2
Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
Co-authored papers 2
Guo Chen
China Pharmaceutical University
Co-authored papers 2
Valer Gotea
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 2
Laura Elnitski
National Human Genome Research Institute
Co-authored papers 2
Umesh Bhanot
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Arie Admon
Co-authored papers 2
Release 1.2